首页> 外文期刊>Indian Journal of Psychological Medicine >Low-frequency Repetitive Transcranial Magnetic Stimulation for Treatment of Tourette Syndrome: A Naturalistic Study with 3 Months of Follow-up
【24h】

Low-frequency Repetitive Transcranial Magnetic Stimulation for Treatment of Tourette Syndrome: A Naturalistic Study with 3 Months of Follow-up

机译:低频重复经颅磁刺激治疗抽动秽语综合征:3个月的随访自然研究。

获取原文
           

摘要

The objective of this study is to report the effects of low-frequency repetitive transcranial magnetic stimulation (rTMS) in three patients with medication-refractory Tourette syndrome (TS) and over 3-month follow-up. A review of literature on the use of rTMS for the treatment of TS is also presented. Three patients with severe, medication-refractory TS and comorbid obsessive-compulsive disorder (OCD) in two of them, received an open-label trial of rTMS at 1 Hz frequency for 4-week duration. The first two cases of TS-OCD showed, on average, around 57% improvement in Yale Global Tic Severity Scale (YGTSS) scores (65% and 50%) and 45% improvement in Yale-Brown Obsessive-compulsive Scale (Y-BOCS) scores; however, the third case of pure-TS showed marginal improvement of 10% only. The improvement in TS-OCD patients with rTMS treatment was maintained at the end of 3-month follow-up, with an average reduction of about 49% (58% and 40%) and 36% observed in YGTSS and Y-BOCS scores, respectively. The present study supports the use of low-frequency rTMS to improve tics and OCD symptoms in patients with severe, medication-refractory TS-OCD. Further, the beneficial effects of rTMS treatment were maintained substantially over 3-month follow-up period.
机译:这项研究的目的是报告低频重复经颅磁刺激(rTMS)对三例药物难治性Tourette综合征(TS)的患者以及超过3个月的随访的影响。还介绍了有关使用rTMS治疗TS的文献综述。其中三名患有严重的药物难治性TS并存并存强迫症的患者接受了一项以1 Hz频率进行rTMS的开放标签试验,持续4周。 TS-OCD的前两个案例显示,耶鲁全球Tic严重量表(YGTSS)评分平均分别提高了约57%(65%和50%),耶鲁-布朗强迫症量表(Y-BOCS)平均提高了45% )分数;但是,第三例纯TS仅显示了10%的边际改进。接受rTMS治疗的TS-OCD患者的改善在3个月的随访结束时得以保持,YGTSS和Y-BOCS评分平均降低了约49%(分别为58%和40%)和36%,分别。本研究支持使用低频rTMS改善患有严重药物难治性TS-OCD的患者的抽动和OCD症状。此外,rTMS治疗的有益效果在3个月的随访期内基本得以维持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号